Gd-Tex gadolinium texaphyrin radiation sensitizer: PCYC began two Phase I trials.

Pharmacyclics Inc. (PCYC), Sunnyvale, Calif. Product: Gd-Tex gadolinium texaphyrin radiation sensitizer Indication: Treat primary brain tumors Status: PCYC began two Phase I trials. In the dose-rangin...